Literature DB >> 11096703

Neuroborreliosis (Nervous System Lyme Disease).

.   

Abstract

Treatment of nervous system Lyme disease depends on the severity and site of involvement. Although some data indicate that uncomplicated Lyme meningitis can be treated effectively with oral doxycycline, central nervous system infection (meningitis, radiculitis, encephalomyelitis, and cranial neuritis) is usually treated with parenteral antibiotics for 14 to 30 days, depending on disease severity, as is severe and progressive peripheral nervous system involvement. Ceftriaxone, 2 g/d, is the most commonly used regimen; cefotaxime, 2 g every 8 hours, appears to be equally effective. Penicillin in meningeal doses is also effective, perhaps slightly less so than the third-generation cephalosporins, but it is less convenient to administer. For patients with prohibitive drug allergies, treatment with oral doxycycline in doses of 300 to 400 mg/d may be effective. In patients with facial palsy or with indolent peripheral neuropathies, a trial of oral medication (doxycycline, 100 mg two or three times a day, or amoxicillin, 500 to 1000 mg three times a day for 21 to 30 days) is reasonable. Patients for whom this fails are treated with parenteral medications.

Entities:  

Year:  1999        PMID: 11096703     DOI: 10.1007/s11940-999-0013-9

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  12 in total

1.  The consequences of overdiagnosis and overtreatment of Lyme disease: an observational study.

Authors:  M C Reid; R T Schoen; J Evans; J C Rosenberg; R I Horwitz
Journal:  Ann Intern Med       Date:  1998-03-01       Impact factor: 25.391

2.  Test-treatment strategies for patients suspected of having Lyme disease: a cost-effectiveness analysis.

Authors:  G Nichol; D T Dennis; A C Steere; R Lightfoot; G Wells; B Shea; P Tugwell
Journal:  Ann Intern Med       Date:  1998-01-01       Impact factor: 25.391

3.  Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis.

Authors:  M Karlsson; S Hammers-Berggren; L Lindquist; G Stiernstedt; B Svenungsson
Journal:  Neurology       Date:  1994-07       Impact factor: 9.910

4.  Lyme disease in children in southeastern Connecticut. Pediatric Lyme Disease Study Group.

Authors:  M A Gerber; E D Shapiro; G S Burke; V J Parcells; G L Bell
Journal:  N Engl J Med       Date:  1996-10-24       Impact factor: 91.245

5.  Treatment of late Lyme borreliosis--randomised comparison of ceftriaxone and penicillin.

Authors:  R J Dattwyler; J J Halperin; D J Volkman; B J Luft
Journal:  Lancet       Date:  1988-05-28       Impact factor: 79.321

6.  Comparison of cefuroxime axetil and doxycycline in treatment of patients with early Lyme disease associated with erythema migrans.

Authors:  S W Luger; P Paparone; G P Wormser; R B Nadelman; E Grunwaldt; G Gomez; M Wisniewski; J J Collins
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191

7.  Cefotaxime vs penicillin G for acute neurologic manifestations in Lyme borreliosis. A prospective randomized study.

Authors:  H W Pfister; V Preac-Mursic; B Wilske; K M Einhäupl
Journal:  Arch Neurol       Date:  1989-11

8.  Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group.

Authors:  A C Steere; V K Sikand; F Meurice; D L Parenti; E Fikrig; R T Schoen; J Nowakowski; C H Schmid; S Laukamp; C Buscarino; D S Krause
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245

9.  Invasion of the central nervous system by Borrelia burgdorferi in acute disseminated infection.

Authors:  B J Luft; C R Steinman; H C Neimark; B Muralidhar; T Rush; M F Finkel; M Kunkel; R J Dattwyler
Journal:  JAMA       Date:  1992-03-11       Impact factor: 56.272

10.  Azithromycin compared with amoxicillin in the treatment of erythema migrans. A double-blind, randomized, controlled trial.

Authors:  B J Luft; R J Dattwyler; R C Johnson; S W Luger; E M Bosler; D W Rahn; E J Masters; E Grunwaldt; S D Gadgil
Journal:  Ann Intern Med       Date:  1996-05-01       Impact factor: 25.391

View more
  2 in total

1.  Diagnosis and treatment of the neuromuscular manifestations of lyme disease.

Authors:  John J Halperin
Journal:  Curr Treat Options Neurol       Date:  2007-03       Impact factor: 3.598

Review 2.  Neuropsychological functioning in chronic Lyme disease.

Authors:  Holly James Westervelt; Robert J McCaffrey
Journal:  Neuropsychol Rev       Date:  2002-09       Impact factor: 6.940

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.